BMY
Bristol-Myers Squibb
PEG ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: BMY
- PEG Ratio
Bristol-Myers Squibb is trading with a PEG ratio of 0.17, based on Jul 31, 2026 data. Dividing the 14.35 PE ratio by the 82.7% earnings growth rate yields this valuation metric. Relative to the 0.21 average from the previous four quarters, the PEG ratio has contracted by 18%.
BMY PEG ratio history
Historically, Bristol-Myers Squibb shows a PEG ratio averaging 0.26 across the past ten years. At 0.17, today's PE to growth ratio sits 35% below its historical average. The ten years high occurred in the Mar 2023 quarter at 0.92, reflecting maximum valuation relative to growth. The minimum was hit in the Jun 2019 quarter at 0.01, indicating optimal value relative to growth during that period.
Bristol-Myers Squibb PEG ratio by year
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.09 | 15.54 | 178.7% |
| 2024 | N/A | N/A | -213.7% |
| 2023 | 0.43 | 13.22 | 30.6% |
| 2022 | N/A | 24.23 | -5.7% |
| 2021 | 0.11 | 19.79 | 178.9% |
| 2020 | N/A | N/A | -297.5% |
| 2019 | N/A | 31.78 | -32.9% |
| 2018 | 0.04 | 17.27 | 393.4% |
| 2017 | N/A | 100.46 | -77.2% |
| 2016 | 0.12 | 21.89 | 184% |
| 2015 | N/A | 73.18 | -22.3% |
| 2014 | N/A | 48.79 | -22.4% |
| 2013 | 1.02 | 34.07 | 33.3% |
| 2012 | N/A | 27.85 | -46.3% |
| 2011 | 0.77 | 16.17 | 21.1% |
Bristol-Myers Squibb PEG ratio by quarter (TTM)
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Jun 2026 | 0.15 | 12.66 | 82.7% |
| Mar 2026 | 0.51 | 16.99 | 33.2% |
| Dec 2025 | 0.09 | 15.54 | 178.7% |
| Sep 2025 | 0.08 | 15.19 | 182.7% |
| Jun 2025 | 0.11 | 18.59 | 176.6% |
| Mar 2025 | 0.12 | 22.76 | 186.7% |
| Dec 2024 | N/A | N/A | -213.7% |
| Sep 2024 | N/A | N/A | -190.4% |
| Jun 2024 | N/A | N/A | -186% |
| Mar 2024 | N/A | N/A | -189.3% |
| Dec 2023 | 0.43 | 13.22 | 30.6% |
| Sep 2023 | 0.51 | 14.62 | 28.5% |
| Jun 2023 | 0.7 | 16.92 | 24.3% |
| Mar 2023 | 0.92 | 20.03 | 21.8% |
| Dec 2022 | N/A | 24.23 | -5.7% |
BMY average PEG ratio chart
Measured against past performance, BMY's PEG ratio is below the 3, 5 and 10-year averages.
PEG comparison
With a PEG of 0.17, BMY is below the Healthcare sector and the industry average. Compared to its Healthcare sector average of 0.56, Bristol-Myers Squibb's PEG is 70% lower.
BMY EPS growth
BMY Price vs fair value
BMY PEG vs peers
Compared to its peer stocks LLY and AZN, BMY's PEG ratio sits lower.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| BMY Bristol-Myers Squibb Company | 0.17 | $131.84B |
| LLY Lilly(Eli) & Company | 0.31 | $1.06T |
| AMGN AMGEN Inc | 0.85 | $206.25B |
| AZN Astrazeneca plc | 0.89 | $241.13B |
| MRK Merck & Co Inc | N/A | $316.38B |
| PFE Pfizer Inc | N/A | $142.37B |
| NVS Novartis AG | N/A | $293.47B |
| JNJ Johnson & Johnson | N/A | $607.73B |
| ABBV Abbvie Inc | N/A | $434.75B |
| ABT Abbott Laboratories | N/A | $185.72B |
Frequently asked questions
What is Bristol-Myers Squibb's PEG ratio?
BMY's Jul 31, 2026 PEG ratio comes in at 0.17.
What is the 3-year average PEG ratio for Bristol-Myers Squibb (BMY)?
BMY has a 3-year average PEG ratio of 0.25.
What is the 5-year average PEG ratio for Bristol-Myers Squibb (BMY)?
BMY has a 5-year average PEG ratio of 0.29.
What is the highest PEG ratio for BMY?
In the last ten years, BMY's peak PEG ratio of 0.92 was recorded in the Mar 2023 quarter.
How does the current PEG ratio for BMY compare to its historical average?
Compared to the 10-year average, BMY's PEG ratio is 35% lower.
Why is Bristol-Myers Squibb's PEG ratio so low?
Strong earnings growth relative to valuation produces BMY's low PEG ratio of 0.17.
How is BMY's PEG ratio calculated (Bristol-Myers Squibb PEG ratio formula)?
The PEG ratio comes from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Jul 31, 2026, Bristol-Myers Squibb has a P/E ratio of 14.35. Earnings grew at 82.7% over the TTM period ending Jun 2026. Applying the formula, this produces a price to earnings growth ratio of 0.17. PEG RATIO(0.17) = PE RATIO(14.35) / EPS GROWTH(82.7%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.